Latest On Adamis Pharmaceuticals Corporation (ADMP):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-19 20:46 EST | News | Adamis Pharma slips 19% on plans for reverse stock slip | N/A |  |
| 2023-05-15 20:16 EST | News | Adamis Pharmaceuticals GAAP EPS of -$0.06, revenue of $1.45M | N/A | |
| 2023-05-15 20:15 EST | News | Adamis Pharmaceuticals Corporation (ADMP) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-03-17 20:15 EST | News | Adamis Pharmaceuticals Corporation (ADMP) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-03-17 05:01 EST | News | Adamis Pharmaceuticals GAAP EPS of -$0.18, revenue of $4.75M | N/A | |
| 2023-03-14 16:16 EST | News | Adamis Pharmaceuticals drops on $3M securities offering | N/A | |
| 2023-02-24 00:46 EST | News | Nasdaq grants Adamis Pharmaceuticals’ request for continued listing on Nasdaq | N/A | |
| 2022-11-15 14:33 EST | News | Adamis Pharmaceuticals Corporation (ADMP) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-14 21:45 EST | News | Adamis Pharmaceuticals GAAP EPS of -$0.03, revenue of $1.51M | N/A | |
| 2022-10-03 22:01 EST | News | Adamis Pharmaceuticals considers sale of company as part of strategic alternatives review | N/A | |
| 2022-10-01 05:46 EST | News | Adamis Pharmaceuticals: Managing A Position In A Company Diagnosed With Chronic Failure | N/A | |
| 2022-09-21 21:02 EST | News | Adamis says Phase 2/3 trial for COVID-19 therapy did not reach main goal | N/A | |
| 2022-08-11 22:15 EST | News | Adamis Pharmaceuticals Corporation (ADMP) CEO David J. Marguglio on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-11 05:31 EST | News | Adamis Pharmaceuticals GAAP EPS of -$0.06 misses by $0.02, revenue of $0.04M misses by $0.36M | N/A | |
| 2022-07-30 00:02 EST | News | Next meeting of data safety board to review Adamis Pharma's COVID treatment in Sept. | N/A | |
| 2022-07-22 11:18 EST | News | Adamis CEO urges stock split approval, slate of directors in letter to shareholders | N/A | |
| 2022-05-18 20:45 EST | News | Adamis Pharmaceuticals names co-founder David Marguglio as CEO | N/A | |
| 2022-05-18 02:16 EST | News | Adamis Pharma stock falls 9% despite better-than expected Q1 revenue | N/A | |
| 2022-05-17 02:45 EST | News | Adamis Pharmaceuticals reports Q1 results | N/A | |
| 2022-05-17 02:45 EST | News | Adamis Pharmaceuticals Corporation (ADMP) CEO Dennis Carlo on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-04-14 04:16 EST | News | Adamis Pharmaceuticals: Preparing For Another Round Of Success, Failure, Then Hope | N/A | |
| 2022-04-01 02:01 EST | News | Adamis Pharmaceuticals reports Q4 results | N/A | |
| 2022-04-01 02:01 EST | News | Adamis Pharmaceuticals Corporation (ADMP) CEO Dr. Dennis Carlo on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-03-14 23:02 EST | News | Adamis' COVID treatment gets OK to proceed in phase 2/3 from DSMB | N/A | |
| 2022-03-04 18:01 EST | News | Adamis pharmaceuticals chairman to retire | N/A | |
| 2022-03-01 02:16 EST | News | Adamis phase 2/3 trial of Tempol for COVID-19 gets safety board's nod | N/A | |
| 2022-01-20 15:16 EST | News | Adamis Pharmaceuticals: Market Continues To Overlook TEMPOL's Potential To Be A Leading COVID-19 Therapeutic | N/A | |
| 2021-12-02 12:17 EST | News | Adamis Pharmaceuticals: It's Now Or Never | N/A | |
| 2021-11-24 13:17 EST | News | Warning: ADMP is at high risk of performing badly | N/A | |
| 2021-11-23 16:19 EST | News | Adamis Pharmaceuticals Corporation (ADMP) CEO Dennis Carlo on Q3 2021 Result - Earnings Call Transcript | N/A | |
| 2021-11-23 16:15 EST | News | Adamis Pharmaceuticals regains Nasdaq compliance | N/A | |
| 2021-10-19 04:47 EST | News | Adamis shares surge more than 42% after FDA approves opioid overdose treatment ZIMHI | N/A | |
| 2021-09-04 05:46 EST | News | Adamis Pharmaceuticals: TEMPOL's Near-Term And Long-Term Upside Improves As Variants Sidestep Vaccines | N/A | |
| 2021-09-02 14:03 EST | News | Adamis gets dosing underway in phase 2/3 Tempol COVID-19 trial | N/A | |
| 2021-08-24 17:01 EST | News | Adamis Pharmaceuticals names David Benedicto CFO | N/A | |
| 2021-08-19 22:04 EST | News | Adamis says NIH identifies Tempol as a potential home therapy against COVID-19 | N/A | |
| 2021-08-17 08:02 EST | News | David Einhorn's Greenlight Capital takes new stake in Adamis, exits ADT: 13F | N/A | |
| 2021-08-02 11:46 EST | News | Exicure, Infinity Pharmaceuticals leads healthcare gainers; TG Therapeutics, Immunovant among major losers | N/A | |
| 2021-07-20 18:01 EST | News | Adamis pharmaceuticals gets deficiency letter from NASDAQ | N/A | |
| 2021-07-20 17:55 EST | News | Adamis Pharma climbs as NIH highlights TEMPOL as potential COVID-19 therapy | N/A | |
| 2021-07-20 17:53 EST | News | Adamis Pharma gains 9% after Tempol shows potential as an antiviral drug for COVID-19 | N/A | |
| 2021-07-20 17:51 EST | News | Adamis Pharma soars 18% after FDA accepts Zimhi application for review | N/A | |
| 2021-07-20 17:47 EST | News | Adamis begins clinical trial start-up activities for COVID drug; shares rise 5% | N/A | |
| 2021-07-20 17:47 EST | News | Adamis Pharmaceuticals: Potential COVID Drug Could Reignite Shares | N/A | |
| 2021-04-16 08:32 EST | News | Adamis Pharmaceuticals misses on revenue | N/A | |
| 2021-04-14 20:47 EST | News | Adamis Pharmaceuticals: Upcoming Catalysts Support Speculative Buy | N/A | |
| 2021-02-22 16:16 EST | News | Adamis gets FDA greenlight for tempol human studies in COVID-19 | N/A | |
| 2021-02-17 16:18 EST | News | Adamis strengthens patent portfolio for ZIMHI opioid overdose treatment | N/A | |
| 2021-01-29 13:01 EST | News | Adamis Pharmaceuticals (ADMP) trades sharply lower after pricing public offering | N/A | |
| 2021-01-28 19:31 EST | News | Adamis Pharmaceuticals plunges in red after hours; stock offering on deck | N/A | |
About Adamis Pharmaceuticals Corporation (ADMP):
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy and respiratory disease in the United States. The company's specialty pharmaceutical product candidates comprise Symjepi (epinephrine) Injection pre-filled syringe (PFS) for use in the emergency treatment of acute allergic reactions, including anaphylaxis. It also offers dry powder inhaler products consisting of fluticasone (APC-4000) for the treatment of asthma; beclomethasone (APC-1000), a metered dose inhaler product for the asthma; Tadalafil (APC-8000) for the treatment of erectile dysfunction; and naloxone injection product candidates (APC-6000) for the treatment of opioid overdose. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, injectables, urological preparations, topical compounds for pain, and men's and women's health products; and certain veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation is headquartered in San Diego, California.
General
- Name Adamis Pharmaceuticals Corporation
- Symbol ADMP
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- Full Time Employees 131
- Last Split Factor1:17
- Last Split Date2013-12-13
- Fiscal Year EndDecember
- IPO Date1995-08-14
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Gic SubIndustryPharmaceuticals
- Web URLhttp://www.adamispharmaceuticals.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 4.19
- Price/Book (Most Recent Quarter) 5.68
- Enterprise Value Revenue 8.15
View More
Financials
- Most Recent Quarter 2020-09-30
- Next Quarter EPS Estimate -$0.06
- Profit Margin -188%
- Operating Margin -158%
- Return on Assets -38%
- Return on Equity -103%
- Revenue 18.43 million
- Earnings Per Share -$0.83
- Revenue Per Share $0.27
- Gross Profit 6.31 million
- Quarterly Earnings Growth -27.1%
View More
Highlights
- Market Capitalization 145.89 million
- EBITDA -35849880
- PE Ratio -0.29
- Analyst Target Price $1
- Book Value Per Share $0.29
View More
Share Statistics
- Shares Outstanding 140.28 million
- Shares Float 92.97 million
- % Held by Insiders 80%
- % Held by Institutions 7.05%
- Shares Short 3.24 million
- Shares Short Prior Month 4.13 million
- Short Ratio 0.19
- Short % of Float 2%
- Short % of Shares Outstanding 2%
View More
Technicals
- Beta 1.41
- 52 Week High $1.8
- 52 Week Low $0.32
- 50 Day Moving Average 1.22
- 200 Day Moving Average 0.84
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Adamis Pharmaceuticals Corporation (ADMP) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Adamis Pharmaceuticals Corporation (ADMP) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-11-09 | $N/A | -$0.10 | -$0.09 | -17.65% |
| 2020-06-30 | 2020-08-17 | $3.93 million | -$0.15 | -$0.08 | -87.5% |
| 2020-03-31 | 2020-05-18 | $4.66 million | -$0.15 | -$0.07 | -114.29% |
| 2019-12-31 | 2020-03-30 | $N/A | -$0.08 | -$0.07 | -23.08% |
| 2019-09-30 | 2019-11-12 | $5.9 million | -$0.12 | -$0.10 | -26.32% |
| 2019-06-30 | 2019-08-08 | $5.76 million | -$0.16 | -$0.13 | -23.08% |
| 2019-03-31 | 2019-05-09 | $4.91 million | -$0.19 | -$0.17 | -15.15% |
| 2018-12-31 | 2019-03-15 | $4.15 million | -$0.28 | -$0.17 | -64.71% |
| 2018-09-30 | 2018-11-09 | $3.83 million | -$0.21 | -$0.15 | -43.15% |
| 2018-06-30 | 2018-08-09 | $3.92 million | -$0.29 | -$0.19 | -54.67% |
| 2018-03-31 | 2018-05-10 | $3.18 million | -$0.23 | -$0.17 | -35.29% |
| 2017-12-31 | 2018-03-16 | $2.84 million | -$0.24 | -$0.15 | -56.56% |
| 2017-09-30 | 2017-11-14 | $3.39 million | -$0.21 | -$0.16 | -28.6% |
| 2017-06-30 | 2017-08-14 | $3.81 million | -$0.19 | -$0.13 | -46.15% |
| 2017-03-31 | 2017-05-12 | $3.04 million | -$0.26 | -$0.20 | -33.33% |
| 2016-12-31 | 2017-03-30 | $2.47 million | -$0.30 | -$0.24 | -25% |
| 2016-09-30 | 2016-11-14 | $2.08 million | -$0.41 | -$0.48 | 14.58% |
| 2016-06-30 | 2016-08-15 | $1.93 million | -$0.37 | -$0.16 | -131.25% |
| 2016-03-31 | 2016-05-13 | $N/A | -$0.48 | -$0.15 | -220% |
| 2015-12-31 | 2016-03-23 | $N/A | -$0.27 | -$0.22 | -22.73% |
| 2015-09-30 | 2015-11-09 | $N/A | -$0.24 | ||
| 2015-06-30 | 2015-08-07 | $N/A | -$0.27 | ||
| 2015-03-31 | 2015-05-14 | $N/A | -$0.32 | ||
| 2014-12-31 | 2015-03-26 | $N/A | -$0.56 | -$0.22 | -153.23% |
| 2014-09-30 | 2014-11-14 | $N/A | -$0.20 | -$0.13 | -53.85% |
| 2014-06-30 | 2014-08-13 | $N/A | -$0.27 | -$0.18 | -50% |
| 2014-03-31 | 2014-06-23 | $N/A | -$0.18 | -$0.16 | -12.5% |
| 2013-12-31 | 2014-02-14 | $N/A | -$0.82 | -$0.20 | -310% |
| 2012-12-31 | 2013-02-13 | $N/A | -$0.34 | ||
| 2012-09-30 | 2012-11-28 | $N/A | -$0.15 | ||
| 2012-06-30 | 2012-08-15 | $N/A | -$0.48 | ||
| 2012-03-31 | 2012-05-30 | $N/A | -$0.23 | ||
| 2011-12-31 | 2012-02-15 | $N/A | -$0.18 | ||
| 2011-09-30 | 2011-11-30 | $N/A | -$0.28 | ||
| 2011-06-30 | 2011-08-10 | $N/A | -$0.26 | ||
| 2011-03-31 | 2011-06-01 | $N/A | -$0.31 | ||
| 2010-12-31 | 2011-02-16 | $N/A | -$0.75 | ||
| 2010-09-30 | 2010-12-01 | $N/A | -$0.77 | ||
| 2010-06-30 | 2010-08-11 | $N/A | -$0.75 | ||
| 2009-12-31 | 2010-03-03 | $-126000 | -$0.56 | ||
| 2009-09-30 | 2009-11-25 | $126000 | -$0.41 | ||
| 2008-06-30 | 2008-07-29 | -$2.20 | |||
| 2008-03-31 | 2008-05-14 | -$2.82 | |||
| 2007-12-31 | 2008-02-27 | -$3.41 | |||
| 2007-09-30 | 2007-11-14 | -$1.82 | |||
| 2007-06-30 | 2007-07-31 | -$2.64 | |||
| 2007-03-31 | 2007-05-16 | -$3.04 | |||
| 2006-12-31 | 2007-02-28 | $84.66 | |||
| 2006-09-30 | 2006-11-15 | -$9.28 | |||
| 2006-06-30 | 2006-08-11 | -$7.08 | |||
| 2006-03-31 | 2006-05-17 | -$13.30 | |||
| 2005-09-30 | 2005-11-15 | -$15.80 | |||
| 2005-06-30 | 2005-08-15 | $27.53 | |||
| 2005-03-31 | 2005-05-16 | -$32.85 | |||
| 2004-12-31 | 2005-03-29 | -$147.52 | |||
| 2004-09-30 | 2004-11-10 | -$23.69 | |||
| 2004-06-30 | 2004-08-10 | -$22.72 | |||
| 2004-03-31 | 2004-05-16 | -$25.70 | |||
| 2003-12-31 | 2004-03-25 | -$32.55 | |||
| 2003-09-30 | 2003-11-06 | -$16.59 | |||
| 2003-06-30 | 2003-08-12 | -$38.82 | -$28.69 | -35.31% | |
| 2003-03-31 | 2003-04-29 | -$27.01 | -$29.54 | 8.56% | |
| 2002-12-31 | 2003-02-27 | -$21.94 | -$21.94 | 0% | |
| 2002-09-30 | 2002-11-11 | -$27.01 | -$36.29 | 25.57% | |
| 2002-06-30 | 2002-08-06 | -$54.01 | -$43.89 | -23.06% | |
| 2002-03-31 | 2002-05-02 | -$42.20 | -$43.32 | 2.59% | |
| 2001-12-31 | 2002-02-21 | -$35.45 | -$41.78 | 15.15% | |
| 2001-09-30 | 2001-11-05 | -$38.82 | -$33.76 | -14.99% | |
| 2001-06-30 | 2001-07-26 | -$48.95 | -$47.26 | -3.58% | |
| 2001-03-31 | 2001-04-24 | -$45.57 | -$48.11 | 5.28% | |
| 2000-12-31 | 2001-02-27 | -$47.26 | -$48.95 | 3.45% | |
| 2000-09-30 | 2000-10-31 | -$42.20 | -$47.26 | 10.71% | |
| 2000-03-31 | 2000-04-20 | -$27.01 | -$37.13 | 27.26% | |
| 1999-12-31 | 2000-02-25 | -$28.69 | -$38.82 | 26.09% | |
| 1999-09-30 | 1999-11-02 | -$28.69 | -$38.82 | 26.09% | |
| 1999-06-30 | 1999-07-29 | -$37.13 | -$32.07 | -15.78% | |
| 1999-03-31 | 1999-04-29 | -$43.89 | -$40.51 | -8.34% | |
| 1998-12-31 | 1999-02-25 | -$30.38 | -$48.95 | 37.94% | |
| 1998-09-30 | 1998-11-04 | -$33.76 | -$43.89 | 23.08% | |
| 1998-06-30 | 1998-08-05 | -$37.13 | -$25.32 | -46.64% | |
| 1998-03-31 | 1998-04-01 | -$35.45 | -$109.72 | 67.69% | |
| 1997-12-31 | 1998-03-31 | -$35.45 | -$109.72 | 67.69% | |
| 1997-09-30 | 1997-12-03 | -$16.88 | -$109.72 | 84.62% |
Adamis Pharmaceuticals Corporation (ADMP) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Adamis Pharmaceuticals Corporation (ADMP) Chart:
Adamis Pharmaceuticals Corporation (ADMP) News:
Below you will find a list of latest news for Adamis Pharmaceuticals Corporation (ADMP) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Adamis Pharmaceuticals Corporation (ADMP) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Latest ADMP Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 3:29 PM EST | 100 | $0.4 |
| Jun 13, 2022 4:08 PM EST | 200 | $0.425 |
| Jun 13, 2022 1:52 PM EST | 100 | $0.43 |
| Jun 13, 2022 7:58 PM EST | 100 | $0.4223 |
| Jun 13, 2022 7:59 PM EST | 1 | $0.4219 |
Adamis Pharmaceuticals Corporation (ADMP) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-30 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/887247/000138713120006021/0001387131-20-006021-index.htm |
| 2019-08-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/887247/000101359419000493/0001013594-19-000493-index.htm |
| 2020-02-13 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/887247/000101359420000135/0001013594-20-000135-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/887247/000101359420000153/0001013594-20-000153-index.htm |
| 2019-08-09 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/887247/000110465919045048/0001104659-19-045048-index.htm |
| 2020-02-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/887247/000110465920013400/0001104659-20-013400-index.htm |
| 2020-02-28 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/887247/000110465920026631/0001104659-20-026631-index.htm |
| 2018-07-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713118002954/0001387131-18-002954-index.htm |
| 2018-07-09 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/887247/000138713118003074/0001387131-18-003074-index.htm |
| 2018-07-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713118003085/0001387131-18-003085-index.htm |
| 2018-07-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000138713118003090/0001387131-18-003090-index.htm |
| 2018-07-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000138713118003092/0001387131-18-003092-index.htm |
| 2018-07-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000138713118003094/0001387131-18-003094-index.htm |
| 2018-07-18 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/887247/000138713118003190/0001387131-18-003190-index.htm |
| 2018-08-01 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/887247/000138713118003502/0001387131-18-003502-index.htm |
| 2018-08-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713118003511/0001387131-18-003511-index.htm |
| 2018-08-03 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/887247/000138713118003564/0001387131-18-003564-index.htm |
| 2018-08-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/887247/000138713118003822/0001387131-18-003822-index.htm |
| 2018-08-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713118003866/0001387131-18-003866-index.htm |
| 2018-09-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713118004524/0001387131-18-004524-index.htm |
| 2018-09-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713118005034/0001387131-18-005034-index.htm |
| 2018-11-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/887247/000138713118006055/0001387131-18-006055-index.htm |
| 2018-11-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713118006204/0001387131-18-006204-index.htm |
| 2018-12-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713118006696/0001387131-18-006696-index.htm |
| 2019-01-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713119000279/0001387131-19-000279-index.htm |
| 2019-01-25 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/887247/000138713119000471/0001387131-19-000471-index.htm |
| 2019-02-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713119000879/0001387131-19-000879-index.htm |
| 2019-03-15 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/887247/000138713119001966/0001387131-19-001966-index.htm |
| 2019-04-30 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/887247/000138713119003177/0001387131-19-003177-index.htm |
| 2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/887247/000138713119003481/0001387131-19-003481-index.htm |
| 2019-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713119003483/0001387131-19-003483-index.htm |
| 2019-05-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713119003857/0001387131-19-003857-index.htm |
| 2019-06-25 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/887247/000138713119004618/0001387131-19-004618-index.htm |
| 2019-07-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713119005408/0001387131-19-005408-index.htm |
| 2019-07-30 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713119005463/0001387131-19-005463-index.htm |
| 2019-07-31 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/887247/000138713119005589/0001387131-19-005589-index.htm |
| 2019-08-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713119005640/0001387131-19-005640-index.htm |
| 2019-08-01 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/887247/000138713119005642/0001387131-19-005642-index.htm |
| 2019-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/887247/000138713119005888/0001387131-19-005888-index.htm |
| 2019-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713119005893/0001387131-19-005893-index.htm |
| 2019-08-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713119006413/0001387131-19-006413-index.htm |
| 2019-10-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713119007447/0001387131-19-007447-index.htm |
| 2019-10-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713119007549/0001387131-19-007549-index.htm |
| 2019-10-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000138713119007562/0001387131-19-007562-index.htm |
| 2019-10-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000138713119007564/0001387131-19-007564-index.htm |
| 2019-10-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000138713119007566/0001387131-19-007566-index.htm |
| 2019-10-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713119007637/0001387131-19-007637-index.htm |
| 2019-10-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713119007663/0001387131-19-007663-index.htm |
| 2019-11-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/887247/000138713119008553/0001387131-19-008553-index.htm |
| 2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713119008565/0001387131-19-008565-index.htm |
| 2019-11-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713119008996/0001387131-19-008996-index.htm |
| 2019-12-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713119009873/0001387131-19-009873-index.htm |
| 2020-02-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000138713120001553/0001387131-20-001553-index.htm |
| 2020-02-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713120002070/0001387131-20-002070-index.htm |
| 2020-02-24 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/887247/000138713120002090/0001387131-20-002090-index.htm |
| 2020-02-26 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000138713120002169/0001387131-20-002169-index.htm |
| 2020-03-06 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/887247/000138713120002656/0001387131-20-002656-index.htm |
| 2020-03-16 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | https://www.sec.gov/Archives/edgar/data/887247/000138713120002905/0001387131-20-002905-index.htm |
| 2020-03-30 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/887247/000138713120003438/0001387131-20-003438-index.htm |
| 2020-03-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713120003444/0001387131-20-003444-index.htm |
| 2020-04-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713120003918/0001387131-20-003918-index.htm |
| 2020-04-17 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/887247/000138713120003974/0001387131-20-003974-index.htm |
| 2020-04-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713120004166/0001387131-20-004166-index.htm |
| 2020-04-29 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/887247/000138713120004269/0001387131-20-004269-index.htm |
| 2020-05-12 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB | https://www.sec.gov/Archives/edgar/data/887247/000138713120004630/0001387131-20-004630-index.htm |
| 2020-05-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713120004712/0001387131-20-004712-index.htm |
| 2020-05-18 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/887247/000138713120004946/0001387131-20-004946-index.htm |
| 2020-05-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713120004956/0001387131-20-004956-index.htm |
| 2020-06-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713120005652/0001387131-20-005652-index.htm |
| 2020-06-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713120005722/0001387131-20-005722-index.htm |
| 2020-06-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713120005863/0001387131-20-005863-index.htm |
| 2020-06-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713120005865/0001387131-20-005865-index.htm |
| 2020-06-30 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/887247/000138713120006016/0001387131-20-006016-index.htm |
| 2020-06-30 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/887247/000138713120006021/0001387131-20-006021-index.htm |
| 2020-07-10 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/887247/000138713120006317/0001387131-20-006317-index.htm |
| 2020-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713120007076/0001387131-20-007076-index.htm |
| 2020-08-07 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/887247/000138713120007207/0001387131-20-007207-index.htm |
| 2020-08-10 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB | https://www.sec.gov/Archives/edgar/data/887247/000138713120007264/0001387131-20-007264-index.htm |
| 2020-08-17 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/887247/000138713120007644/0001387131-20-007644-index.htm |
| 2020-08-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713120007656/0001387131-20-007656-index.htm |
| 2020-08-21 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/887247/000138713120007749/0001387131-20-007749-index.htm |
| 2020-08-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713120007827/0001387131-20-007827-index.htm |
| 2020-08-24 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/887247/000138713120007829/0001387131-20-007829-index.htm |
| 2020-08-25 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/887247/000138713120007880/0001387131-20-007880-index.htm |
| 2020-09-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713120008220/0001387131-20-008220-index.htm |
| 2020-09-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713120008228/0001387131-20-008228-index.htm |
| 2020-09-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713120008322/0001387131-20-008322-index.htm |
| 2020-09-17 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/887247/000138713120008362/0001387131-20-008362-index.htm |
| 2020-09-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713120008395/0001387131-20-008395-index.htm |
| 2020-09-21 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/887247/000138713120008405/0001387131-20-008405-index.htm |
| 2020-10-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713120008705/0001387131-20-008705-index.htm |
| 2020-10-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/887247/000138713120008772/0001387131-20-008772-index.htm |
| 2020-10-05 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/887247/000138713120008775/0001387131-20-008775-index.htm |
| 2020-10-14 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/887247/000138713120009007/0001387131-20-009007-index.htm |
| 2019-02-11 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/887247/000156761919002903/0001567619-19-002903-index.htm |
| 2020-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/887247/000156761920002049/0001567619-20-002049-index.htm |
| 2019-02-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819000301/0001593968-19-000301-index.htm |
| 2019-02-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819000308/0001593968-19-000308-index.htm |
| 2019-02-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819000309/0001593968-19-000309-index.htm |
| 2019-02-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819000310/0001593968-19-000310-index.htm |
| 2019-02-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819000311/0001593968-19-000311-index.htm |
| 2019-02-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819000315/0001593968-19-000315-index.htm |
| 2019-02-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819000316/0001593968-19-000316-index.htm |
| 2019-02-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819000317/0001593968-19-000317-index.htm |
| 2019-02-12 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819000408/0001593968-19-000408-index.htm |
| 2019-02-12 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819000409/0001593968-19-000409-index.htm |
| 2019-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819000563/0001593968-19-000563-index.htm |
| 2019-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819000564/0001593968-19-000564-index.htm |
| 2019-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819000565/0001593968-19-000565-index.htm |
| 2019-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819000566/0001593968-19-000566-index.htm |
| 2019-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819000567/0001593968-19-000567-index.htm |
| 2019-03-12 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819000765/0001593968-19-000765-index.htm |
| 2019-03-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819000833/0001593968-19-000833-index.htm |
| 2019-03-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819000834/0001593968-19-000834-index.htm |
| 2019-03-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819000835/0001593968-19-000835-index.htm |
| 2019-03-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819000836/0001593968-19-000836-index.htm |
| 2019-03-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819000837/0001593968-19-000837-index.htm |
| 2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819001168/0001593968-19-001168-index.htm |
| 2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819001169/0001593968-19-001169-index.htm |
| 2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819001170/0001593968-19-001170-index.htm |
| 2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819001171/0001593968-19-001171-index.htm |
| 2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819001172/0001593968-19-001172-index.htm |
| 2019-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819001240/0001593968-19-001240-index.htm |
| 2019-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819001241/0001593968-19-001241-index.htm |
| 2019-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819001242/0001593968-19-001242-index.htm |
| 2019-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819001775/0001593968-19-001775-index.htm |
| 2019-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819001777/0001593968-19-001777-index.htm |
| 2019-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819001778/0001593968-19-001778-index.htm |
| 2019-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819001779/0001593968-19-001779-index.htm |
| 2019-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819001780/0001593968-19-001780-index.htm |
| 2019-11-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819002185/0001593968-19-002185-index.htm |
| 2019-11-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819002186/0001593968-19-002186-index.htm |
| 2019-11-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819002187/0001593968-19-002187-index.htm |
| 2019-11-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819002188/0001593968-19-002188-index.htm |
| 2019-11-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396819002189/0001593968-19-002189-index.htm |
| 2020-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396820000520/0001593968-20-000520-index.htm |
| 2020-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396820000521/0001593968-20-000521-index.htm |
| 2020-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396820000522/0001593968-20-000522-index.htm |
| 2020-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396820000523/0001593968-20-000523-index.htm |
| 2020-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396820000524/0001593968-20-000524-index.htm |
| 2020-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396820000860/0001593968-20-000860-index.htm |
| 2020-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396820000861/0001593968-20-000861-index.htm |
| 2020-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396820000862/0001593968-20-000862-index.htm |
| 2020-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396820000863/0001593968-20-000863-index.htm |
| 2020-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396820000864/0001593968-20-000864-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396820001221/0001593968-20-001221-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396820001222/0001593968-20-001222-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396820001223/0001593968-20-001223-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396820001224/0001593968-20-001224-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396820001225/0001593968-20-001225-index.htm |
| 2020-08-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396820001770/0001593968-20-001770-index.htm |
| 2020-08-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396820001771/0001593968-20-001771-index.htm |
| 2020-08-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396820001772/0001593968-20-001772-index.htm |
| 2020-08-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396820001773/0001593968-20-001773-index.htm |
| 2020-08-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396820001774/0001593968-20-001774-index.htm |
| 2020-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396820001949/0001593968-20-001949-index.htm |
| 2020-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/887247/000159396820001950/0001593968-20-001950-index.htm |
| 2018-07-18 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/887247/999999999518001829/9999999995-18-001829-index.htm |
| 2020-10-14 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/887247/999999999520002847/9999999995-20-002847-index.htm |
| 2018-12-18 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/887247/999999999718009602/9999999997-18-009602-index.htm |
Adamis Pharmaceuticals Corporation (ADMP) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Adamis Pharmaceuticals Corporation (ADMP). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 80%Institutional Ownership: 705%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-05-24 | WILLIAM C DENBY | Director | Buy | 6,250.00 | 1.60 | 9,996.88 | 108,750.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819001242/0001593968-19-001242-index.htm |
| 2019-05-24 | ROBERT B ROTHERMEL | Director | Buy | 6,500.00 | 1.58 | 10,270.00 | 133,500.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819001240/0001593968-19-001240-index.htm |
| 2020-08-18 | Karen K. Daniels | VP of Operations | Sell | 5,480.00 | 0.87 | 4,790.07 | 140,664.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396820001770/0001593968-20-001770-index.htm |
| 2020-05-19 | Karen K. Daniels | VP of Operations | Sell | 4,855.00 | 0.56 | 2,719.29 | 146,144.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396820001222/0001593968-20-001222-index.htm |
| 2020-03-18 | Karen K. Daniels | VP of Operations | Sell | 6,461.00 | 0.34 | 2,174.77 | 150,999.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396820000861/0001593968-20-000861-index.htm |
| 2020-02-24 | Karen K. Daniels | VP of Operations | Sell | 6,229.00 | 0.60 | 3,759.20 | 157,460.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396820000521/0001593968-20-000521-index.htm |
| 2019-11-18 | Karen K. Daniels | VP of Operations | Sell | 5,421.00 | 0.83 | 4,499.43 | 163,689.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819002187/0001593968-19-002187-index.htm |
| 2019-08-19 | Karen K. Daniels | VP of Operations | Sell | 5,243.00 | 1.06 | 5,557.58 | 169,110.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819001778/0001593968-19-001778-index.htm |
| 2019-05-20 | Karen K. Daniels | VP of Operations | Sell | 5,591.00 | 1.73 | 9,669.63 | 174,353.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819001171/0001593968-19-001171-index.htm |
| 2019-01-30 | Karen K. Daniels | VP of Operations | Buy | 173,583.00 | 179,944.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819000315/0001593968-19-000315-index.htm | ||
| 2019-03-20 | Karen K. Daniels | VP of Operations | Sell | 13,911.00 | 2.30 | 32,010.60 | 179,944.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819000836/0001593968-19-000836-index.htm |
| 2019-02-21 | Karen K. Daniels | VP of Operations | Buy | 13,911.00 | 193,855.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819000565/0001593968-19-000565-index.htm | ||
| 2020-08-18 | Ronald B. Moss | Chief Medical Officer | Sell | 8,749.00 | 0.87 | 7,647.50 | 226,373.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396820001771/0001593968-20-001771-index.htm |
| 2020-05-18 | Ronald B. Moss | Chief Medical Officer | Sell | 7,736.00 | 0.56 | 4,332.93 | 235,122.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396820001223/0001593968-20-001223-index.htm |
| 2019-05-24 | RICHARD C WILLIAMS | Director | Buy | 50,000.00 | 1.57 | 78,520.00 | 239,918.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819001241/0001593968-19-001241-index.htm |
| 2020-03-18 | Ronald B. Moss | Chief Medical Officer | Sell | 10,337.00 | 0.34 | 3,479.43 | 242,858.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396820000864/0001593968-20-000864-index.htm |
| 2020-02-24 | Ronald B. Moss | Chief Medical Officer | Sell | 6,229.00 | 0.06 | 395.54 | 253,195.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396820000520/0001593968-20-000520-index.htm |
| 2019-11-18 | Ronald B. Moss | Chief Medical Officer | Sell | 8,448.00 | 0.85 | 7,197.70 | 259,424.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819002188/0001593968-19-002188-index.htm |
| 2019-08-19 | Ronald B. Moss | Chief Medical Officer | Sell | 8,383.00 | 1.06 | 8,892.69 | 267,872.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819001775/0001593968-19-001775-index.htm |
| 2020-09-29 | Robert O Hopkins | Chief Financial Officer | Sell | 20,000.00 | 0.80 | 16,000.00 | 274,781.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396820001950/0001593968-20-001950-index.htm |
| 2019-05-20 | Ronald B. Moss | Chief Medical Officer | Sell | 8,741.00 | 1.77 | 15,463.70 | 276,255.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819001170/0001593968-19-001170-index.htm |
| 2019-01-30 | Ronald B. Moss | Chief Medical Officer | Buy | 277,732.00 | 277,732.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819000308/0001593968-19-000308-index.htm | ||
| 2019-03-20 | Ronald B. Moss | Chief Medical Officer | Sell | 6,647.00 | 2.27 | 15,075.40 | 284,996.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819000837/0001593968-19-000837-index.htm |
| 2019-02-21 | Ronald B. Moss | Chief Medical Officer | Buy | 13,911.00 | 291,643.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819000566/0001593968-19-000566-index.htm | ||
| 2020-08-18 | Robert O Hopkins | Chief Financial Officer | Sell | 7,418.00 | 0.87 | 6,484.07 | 294,781.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396820001773/0001593968-20-001773-index.htm |
| 2020-08-18 | DENNIS J PHD CARLO | President & CEO | Sell | 10,929.00 | 0.87 | 9,553.04 | 299,247.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396820001772/0001593968-20-001772-index.htm |
| 2020-05-18 | Robert O Hopkins | Chief Financial Officer | Sell | 6,532.00 | 0.56 | 3,658.57 | 302,199.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396820001225/0001593968-20-001225-index.htm |
| 2020-09-29 | David J. Marguglio | SVP and Chief Business Officer | Sell | 20,000.00 | 0.80 | 16,000.00 | 308,539.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396820001949/0001593968-20-001949-index.htm |
| 2020-03-18 | Robert O Hopkins | Chief Financial Officer | Sell | 8,749.00 | 0.34 | 2,944.91 | 308,731.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396820000862/0001593968-20-000862-index.htm |
| 2020-05-18 | DENNIS J PHD CARLO | President & CEO | Sell | 9,913.00 | 0.56 | 5,552.27 | 310,176.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396820001221/0001593968-20-001221-index.htm |
| 2020-02-24 | Robert O Hopkins | Chief Financial Officer | Sell | 8,420.00 | 0.60 | 5,081.47 | 317,480.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396820000522/0001593968-20-000522-index.htm |
| 2020-03-18 | DENNIS J PHD CARLO | President & CEO | Sell | 10,645.00 | 0.34 | 3,583.11 | 320,089.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396820000860/0001593968-20-000860-index.htm |
| 2020-03-18 | David J. Marguglio | SVP and Chief Business Officer | Sell | 10,337.00 | 0.34 | 3,479.43 | 325,022.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396820000863/0001593968-20-000863-index.htm |
| 2019-11-18 | Robert O Hopkins | Chief Financial Officer | Sell | 7,347.00 | 0.83 | 6,098.74 | 325,900.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819002189/0001593968-19-002189-index.htm |
| 2020-08-18 | David J. Marguglio | SVP and Chief Business Officer | Sell | 8,749.00 | 0.87 | 7,647.50 | 328,539.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396820001774/0001593968-20-001774-index.htm |
| 2020-02-24 | DENNIS J PHD CARLO | President & CEO | Sell | 12,436.00 | 0.60 | 7,505.13 | 330,734.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396820000524/0001593968-20-000524-index.htm |
| 2019-08-19 | Robert O Hopkins | Chief Financial Officer | Sell | 7,101.00 | 1.06 | 7,536.29 | 333,247.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819001779/0001593968-19-001779-index.htm |
| 2019-01-30 | Robert O Hopkins | Chief Financial Officer | Buy | 277,732.00 | 334,549.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819000317/0001593968-19-000317-index.htm | ||
| 2020-02-24 | David J. Marguglio | SVP and Chief Business Officer | Sell | 9,948.00 | 0.60 | 6,003.62 | 335,359.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396820000523/0001593968-20-000523-index.htm |
| 2020-05-18 | David J. Marguglio | SVP and Chief Business Officer | Sell | 7,734.00 | 0.56 | 4,331.81 | 337,288.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396820001224/0001593968-20-001224-index.htm |
| 2019-05-20 | Robert O Hopkins | Chief Financial Officer | Sell | 7,559.00 | 1.73 | 13,108.82 | 340,348.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819001168/0001593968-19-001168-index.htm |
| 2019-11-18 | DENNIS J PHD CARLO | President & CEO | Sell | 10,760.00 | 0.84 | 8,998.59 | 343,170.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819002185/0001593968-19-002185-index.htm |
| 2019-03-20 | Robert O Hopkins | Chief Financial Officer | Sell | 8,900.00 | 2.30 | 20,445.97 | 347,907.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819000834/0001593968-19-000834-index.htm |
| 2019-08-19 | DENNIS J PHD CARLO | President & CEO | Sell | 10,477.00 | 1.06 | 11,117.14 | 353,930.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819001780/0001593968-19-001780-index.htm |
| 2019-02-21 | Robert O Hopkins | Chief Financial Officer | Buy | 22,258.00 | 356,807.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819000564/0001593968-19-000564-index.htm | ||
| 2019-01-30 | DENNIS J PHD CARLO | President & CEO | Buy | 347,165.00 | 361,061.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819000316/0001593968-19-000316-index.htm | ||
| 2019-05-20 | DENNIS J PHD CARLO | President & CEO | Sell | 11,184.00 | 1.73 | 19,339.37 | 364,407.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819001172/0001593968-19-001172-index.htm |
| 2019-11-18 | David J. Marguglio | SVP and Chief Business Officer | Sell | 8,283.00 | 0.87 | 7,197.10 | 365,307.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819002186/0001593968-19-002186-index.htm |
| 2019-08-19 | David J. Marguglio | SVP and Chief Business Officer | Sell | 8,109.00 | 1.10 | 8,883.41 | 373,590.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819001777/0001593968-19-001777-index.htm |
| 2019-01-30 | David J. Marguglio | Sr VP of Business Development | Buy | 277,732.00 | 378,755.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819000311/0001593968-19-000311-index.htm | ||
| 2019-05-20 | David J. Marguglio | SVP and Chief Business Officer | Sell | 8,735.00 | 1.77 | 15,463.57 | 381,699.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819001169/0001593968-19-001169-index.htm |
| 2019-02-21 | DENNIS J PHD CARLO | President & CEO | Buy | 27,822.00 | 388,883.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819000563/0001593968-19-000563-index.htm | ||
| 2019-03-20 | David J. Marguglio | SVP and Chief Business Officer | Sell | 10,579.00 | 2.28 | 24,107.43 | 390,434.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819000833/0001593968-19-000833-index.htm |
| 2019-02-21 | David J. Marguglio | SVP and Chief Business Officer | Buy | 22,258.00 | 401,013.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819000567/0001593968-19-000567-index.htm | ||
| 2019-03-20 | DENNIS J PHD CARLO | President & CEO | Sell | 13,292.00 | 2.27 | 30,132.96 | 42,353.00 | https://www.sec.gov/Archives/edgar/data/887247/000159396819000835/0001593968-19-000835-index.htm |